Xu W, Langhans S, Johnson D, Stauff E, Kandula V, Kecskemethy H
Int J Mol Sci. 2024; 25(17).
PMID: 39273366
PMC: 11395405.
DOI: 10.3390/ijms25179419.
Dou W, Tong P, Xing M, Liu J, Hu X, James T
J Am Chem Soc. 2024; 146(30):21017-21024.
PMID: 39029108
PMC: 11295173.
DOI: 10.1021/jacs.4c06172.
Huang Y, Chen J, Chen S, Huang C, Li B, Li J
Front Cell Infect Microbiol. 2024; 14:1415885.
PMID: 38846351
PMC: 11153676.
DOI: 10.3389/fcimb.2024.1415885.
Zahoor M
Vaccines (Basel). 2023; 11(12).
PMID: 38140216
PMC: 10747374.
DOI: 10.3390/vaccines11121812.
Maschietto C, Otto G, Rouze P, Debortoli N, Bihin B, Nyinkeu L
Sci Rep. 2023; 13(1):6934.
PMID: 37117393
PMC: 10140720.
DOI: 10.1038/s41598-023-34088-w.
Reconstructing early transmission networks of SARS-CoV-2 using a genomic mutation model.
Cheng C, Zhang Z
Zool Res. 2023; 44(3):494-504.
PMID: 36999549
PMC: 10236306.
DOI: 10.24272/j.issn.2095-8137.2022.535.
Fluorescent Marker as a Tool to Improve Strategies to Control Contaminated Surfaces and Decrease Danger of Cross-Contamination in Dental Clinics, during and beyond the COVID-19 Pandemic.
Dolev E, Eli I, Mashkit E, Grinberg N, Emodi-Perlman A
Int J Environ Res Public Health. 2023; 20(6).
PMID: 36982137
PMC: 10049276.
DOI: 10.3390/ijerph20065229.
An update on SARS-CoV-2 immunization and future directions.
Rana R, Kant R, Kumra T, Gupta S, Rana D, Ganguly N
Front Pharmacol. 2023; 14:1125305.
PMID: 36969857
PMC: 10033701.
DOI: 10.3389/fphar.2023.1125305.
A Rapid Method for Generating Infectious SARS-CoV-2 and Variants Using Mutagenesis and Circular Polymerase Extension Cloning.
Kim B, Choi W, Jeong J, Oh S, Park J, Yun Y
Microbiol Spectr. 2023; :e0338522.
PMID: 36877070
PMC: 10100849.
DOI: 10.1128/spectrum.03385-22.
Fidelity of Ribonucleotide Incorporation by the SARS-CoV-2 Replication Complex.
Yin X, Popa H, Stapon A, Bouda E, Garcia-Diaz M
J Mol Biol. 2023; 435(5):167973.
PMID: 36690070
PMC: 9854147.
DOI: 10.1016/j.jmb.2023.167973.
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.
Cantoni D, Siracusano G, Mayora-Neto M, Pastori C, Fantoni T, Lytras S
Vaccines (Basel). 2023; 11(1).
PMID: 36679903
PMC: 9864028.
DOI: 10.3390/vaccines11010058.
Genomic Tracking of SARS-CoV-2 Variants in Myanmar.
Oo K, Htun Z, Aung N, Win K, Linn K, Htoo S
Vaccines (Basel). 2023; 11(1).
PMID: 36679850
PMC: 9862072.
DOI: 10.3390/vaccines11010006.
CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses.
Noto A, Joo V, Mancarella A, Suffiotti M, Pellaton C, Fenwick C
Viruses. 2022; 14(12).
PMID: 36560669
PMC: 9785906.
DOI: 10.3390/v14122665.
Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes.
Serna-Munoz R, Hernandez-Teran A, Soto-Nava M, Tapia-Trejo D, Avila-Rios S, Mejia-Nepomuceno F
Vaccines (Basel). 2022; 10(12).
PMID: 36560474
PMC: 9785259.
DOI: 10.3390/vaccines10122063.
The Spike Mutants Website: A Worldwide Used Resource against SARS-CoV-2.
Romeo I, Prandi I, Giombini E, Gruber C, Pietrucci D, Borocci S
Int J Mol Sci. 2022; 23(21).
PMID: 36361870
PMC: 9654198.
DOI: 10.3390/ijms232113082.
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness.
Tulimilli S, Dallavalasa S, Basavaraju C, Rao V, Chikkahonnaiah P, Madhunapantula S
Vaccines (Basel). 2022; 10(10).
PMID: 36298616
PMC: 9607623.
DOI: 10.3390/vaccines10101751.
Assessing the Compliance of Dental Clinicians towards Regulatory Infection Control Guidelines Using a Newly Developed Survey Tool: A Pilot Cross-Sectional Study in India.
Kaurani P, Batra K, Rathore Hooja H, Chander N, Bhowmick A, Arora S
Healthcare (Basel). 2022; 10(10).
PMID: 36292324
PMC: 9601445.
DOI: 10.3390/healthcare10101877.
Clustered Regularly Interspaced short palindromic repeats-Based Microfluidic System in Infectious Diseases Diagnosis: Current Status, Challenges, and Perspectives.
Xie Y, Li H, Chen F, Udayakumar S, Arora K, Chen H
Adv Sci (Weinh). 2022; 9(34):e2204172.
PMID: 36257813
PMC: 9731715.
DOI: 10.1002/advs.202204172.
Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.
Ruiz M, Siracusano G, Cottignies-Calamarte A, Tudor D, Real F, Zhu A
Front Immunol. 2022; 13:842468.
PMID: 36248831
PMC: 9560774.
DOI: 10.3389/fimmu.2022.842468.
Recent review of COVID-19 management: diagnosis, treatment and vaccination.
Chavda V, Vuppu S, Mishra T, Kamaraj S, Patel A, Sharma N
Pharmacol Rep. 2022; 74(6):1120-1148.
PMID: 36214969
PMC: 9549062.
DOI: 10.1007/s43440-022-00425-5.
